Antonella Giancotti

Dr. Antonella Giancotti

Department of Maternal and Child Health and Urological Sciences, “Sapienza” University of Rome, 00161 Rome, Italy
orcid

Research Focus & Metrics

Academic Career Length

71Years (1956-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 December 2018 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Closed access
PDF file
DMDaniele Di Mascio
Daniele Di Mascio
FSFilomena Giulia Sileo
Filomena Giulia Sileo
Asma KhalilAsma Khalil
Asma Khalil
Giuseppe RizzoGiuseppe Rizzo
Giuseppe Rizzo
NPNicola Persico
Nicola Persico
FDFrancesco D'Antonio
Francesco D'Antonio

1 April 2014 in Critical Care
Verified
Journal Article
Open access
PDF file
AFA Foca
A Foca
CPC Peronace
C Peronace
VMV Marano
V Marano
GBGs Barreca
Gs Barreca
ALAg Lamberti
Ag Lamberti
MLMC Liberto
MC Liberto

1 July 2004 in American Journal of Orthodontics and Dentofacial Orthopedics
Verified
Journal Article
Closed access
Antonella GiancottiAntonella Giancotti
Antonella Giancotti
CAClaudio Arcuri
Claudio Arcuri
ABAlberto Barlattani
Alberto Barlattani

1 June 2001 in Journal of Orthodontics
Verified
Journal Article
Closed access
PCPaola Cozza
Paola Cozza
Antonella GiancottiAntonella Giancotti
Antonella Giancotti
APAntonia Petrosino
Antonia Petrosino
The aims of this investigation were to cephalometrically study the short-term skeletal and dental modifications induced by rapid palatal expansion in a sample of 20 patients (10 male, 10 female), aged 6–10 years (mean age 8 years) in mixed dentition with a uni- or bilateral posterior crossbite, a mild skeletal Class II malocclusion, and an increased vertical dimension (FMA, SN^GoGn), and to compare them with an untreated matched control group of 20 subjects (10 male and 10 female), mean age 8 years.Cephalometric analysis showed that the maxilla displayed a tendency to rotate downwards and backward, resulting in a statistically significant increase of the SN^PP angle (T0 = 9•95 degrees, T1 = 11•60 degrees, P < 0•01) and the SN–ANS linear value (T0 = 49•50 mm, T1 = 51•10 mm, P < 0•05). Table 1. Method error coefficientsVariablesRSNA (°)0•99SNB (°)0•98ANB (°)0•98AO–BO (mm)0•99N perp.–A (mm)0•99N perp.–Pg (mm)0•99PTM–A (mm)0•97FMA (°)0•98SN^GoGn (°)0•98PP^GoGn (°)0•99SN^PP (°)0•97P.occl. ^ FH (°)0•99A...

26 March 2002 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
Giovanni MateraGiovanni Matera
Giovanni Matera
ALAngelo Lamberti
Angelo Lamberti
AQAngela Quirino
Angela Quirino
DFDomenico Focà
Domenico Focà
Antonella GiancottiAntonella Giancotti
Antonella Giancotti
MLMaria Carla Liberto
Maria Carla Liberto

5 April 2013 in Critical Care
Verified
Journal Article
Open access
PDF file
Giovanni MateraGiovanni Matera
Giovanni Matera
RPRossana Puccio
Rossana Puccio
Antonella GiancottiAntonella Giancotti
Antonella Giancotti
AQAngela Quirino
Angela Quirino
MPMaria Concetta Pulicari
Maria Concetta Pulicari
AFAlfredo Focà
Alfredo Focà
Introduction: The pathophysiology of sepsis consists of two phases. A first phase characterized by a substantial increase of pro-inflammatory mediators including cytokines and systemic inflammatory markers, and a second phase (immunoparalysis, immunodysregulation) associated with the rise of anti-inflammatory mediators. In this study we prospectively analyzed 52 consecutive patients with diagnosis of systemic inflammatory response syndrome (SIRS) at hospital admission to evaluate prognostic and early diagnostic performance of interleukin-10 (IL-10), soluble CD25 (sCD25) and interferon-γ (IFN-γ) and to confirm the prognostic accuracy of the sequential organ failure assessment (SOFA) score. Methods: Patients were divided in two groups (group 1, n = 28 patients with bacteremic SIRS and group 2, n = 24 patients with non-bacteremic SIRS) and then stratified into survivors (n = 39) and nonsurvivors (n = 13). Serum markers were evaluated on the day of hospital admission (D-1) and on the 7th day of hospital stay (D-7). Concentration of sCD25 was evaluated by a sandwich ELISA kit. Levels of IL-10 and IFN-γ were quantified by a cytokine biochip array by the evidence investigator analyzer. Differences between groups were established by the Mann-Whitney test. Accuracy, sensitivity and specificity of diagnostic markers were evaluated by the receiver-operating characteristic curve analysis. Multivariate analysis was carried out to evaluate whether studied biomarkers are independent predictors of poor outcome in prognosis, and of bacteremic SIRS in diagnosis. Results: IL-10, sCD25 and SOFA scores of survivors and nonsurvivors were significantly different both at D-1 (P = 0.0014; P = 0.014 and P = 0.0311 respectively) and at D-7 (P = 0.0002, P = 0.014 and P = 0.0012 respectively). Between the above groups IFN-γ level was significantly different only at D-7 (P = 0.0013). Moreover IL-10 and sCD25 were significantly higher in bacteremic versus non-bacteremic SIRS patients at D-1 and at D-7 (P < 0.05). IFN-γ values showed a significant decrease (P < 0.05) in patients of group 1 only at D-7. The diagnostic accuracy of IL-10 and sCD25 was confirmed by the analysis of the AUROCC at D-1 and D-7 respectively. Multivariate analysis revealed that sCD25 and IL-10 are independent predictors of a poor outcome for our patients during the first day of hospital admission. Conclusions: IL-10 and sCD25 gave a significant contribution to prognostic evaluation and early diagnosis of bacteremic SIRS. SOFA score appeared to be a reliable prognostic tool in this subset of patients.